Table 3 Fasting laboratory parameters of ziprasidone and olanzapine-treated patients (n = 10 per group)

Measure

Median (IQR)

Median (IQR)

P^b

Median (IQR)

Median (IQR)

P^b

Median (IQR)

Median (IQR)

P^c

Cholesterol (mg/dl)

153.50 (143.00, 175.00)

171.00 (154.00, 185.25)

0.021^*

176.50 (154.40, 205.75)

200.00 (160.00, 223.50)

0.203

4.95 (1.99, 24.55)

15.39 (−7.49, 22.09)

>0.99

Triglyceride (mg/dl)

89.00 (63.00, 112.75)

88.50 (81.00, 154.25)

0.114

73.50 (58.00, 106.50)

118.00 (71.50, 180.75)

0.086

30.35 (−3.72, 58.04)

62.54 (−3.08, 137.66)

0.290

HDL-C (mg/dl)

49.50 (44.00, 54.25)

58.50 (52.50, 61.50)

0.036^*

59.00 (47.00, 65.25)

50.00 (46.75, 55.75)

0.092

7.36 (1.19, 29.55)

−13.24 (−23.56 , -4.02)

0.008^*

LDL-C (mg/dl)

85.00 (71.55, 104.95)

100.00 (81.50, 109.00)

0.144

106.00 (77.50, 115.00)

129.00 (116.50, 143.00)

0.043^*

7.07 (−0.68, 19.31)

16.04 (3.76, 84.25)

0.347

Glucose (mg/dl)

90.50 (81.75, 95.50)

95.50 (86.75, 98.00)

>0.99

89.50 (83.00, 96.50)

98.00 (87.75, 108.50)

0.241

−1.08 (−6.89, 6.69)

4.58 (−3.38, 17.92)

0.496

Insulin (IU/ml)

9.55 (5.58, 13.18)

6.30 (3.80, 10.35)

0.169

9.25 (5.85, 11.95)

6.75 (3.73, 10.50)

0.333

−25.46 (−47.37, 15.95)

−27.35 (−59.38, 39.37)

0.705

C-peptide (ng/ml)

2.30 (1.15, 2.45)

1.95 (1.25, 2.25)

0.357

1.70 (1.65, 2.33)

2.15 (1.35, 3.23)

0.314

−11.01 (−14.13, 15.56)

8.06 (−18.20, 89.71)

0.273

Prolactin (ng/ml)

9.55 (5.58, 13.18)

7.35 (6.15, 43.30)

0.285

10.95 (7.18, 19.38)

19.10 (11.33, 28.10)

0.028^*

31.40 (−45.21, 262.32)

28.06 (−8.06, 122.40)

0.880